Utility of week-4 viral response to tailor treatment duration in hepatitis C virus genotype 3/HIV co-infected patients.

Crespo, Manuel; Esteban, Juan I; Ribera, Esteban; Falco, Vicenç; Sauleda, Silvia; Buti, María; Esteban, Rafael; Guardia, Jaime; Ocaña, Inma; Pahissa, Albert

Crespo, Manuel; Esteban, Juan I; Ribera, Esteban; Falco, Vicenç; Sauleda, Silvia; Buti, María; Esteban, Rafael; Guardia, Jaime; Ocaña, Inma; Pahissa, Albert.

Affiliation

Crespo M; Infectious Diseases Department, Spain. mcrespo@vhebron.net

AIDS ; 21(4): 477-81, 2007 Feb 19.

Article in En | MEDLINE | ID: mdl-17301566

Subject(s)

Antiviral Agents/administration & dosage; HIV Infections/complications; Hepacivirus/classification; Hepatitis C, Chronic/drug therapy; Interferon-alpha/administration & dosage; Ribavirin/administration & dosage; Adult; Antiviral Agents/therapeutic use; Drug Administration Schedule; Drug Monitoring/methods; Drug Therapy, Combination; Female; Genotype; Hepacivirus/genetics; Hepacivirus/isolation & purification; Hepatitis C, Chronic/complications; Hepatitis C, Chronic/virology; Humans; Interferon alpha-2; Interferon-alpha/therapeutic use; Male; Polyethylene Glycols; RNA, Viral/blood; Recombinant Proteins; Recurrence; Retrospective Studies; Ribavirin/therapeutic use; Treatment Outcome; Viral Load

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Ribavirin / HIV Infections / Interferon-alpha / Hepacivirus / Hepatitis C, Chronic Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male Language: En Journal: AIDS Journal subject: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Year: 2007 Type: Article Affiliation country: Spain

Search on Google

XML

PubMed Links